• Diagnosis, treatment, and second-opinion services from a wide range of cancer care specialists, both in the community and in academic centers, including NCIdesignated cancer centers and comprehensive cancer centers • Routine costs of care when enrolled in a well-designed cancer clinical trial, including coverage when the individual is enrolled in hospice • Hospice when the individual has an estimated life expectancy of 12 months or less (rather than the usual 6 months) • Genetic testing, and biomarker and molecular testing, consistent with recommendations in NCCN Guidelines • Fertility preservation services and dental services under specific circumstances related to cancer treatment Medical and/or pharmacy plan coverage:
• With reasonable levels of patient cost-sharing for drugs and biologics • For drugs and biologics in cancer care based on recommendations in the NCCN Compendium • Parity of patient cost-sharing between the medical and pharmacy benefit plans To view the entire toolkit associated with this project, visit www.businessgrouphealth.org and click on "Cancer" in the Hot Topics list. You can also click on An Employer's Guide to Cancer Treatment and Prevention: Tool 2: Plan Design & Assessment Tool at businessgrouphealth.org/pdfs/CancerTool2.pdf.
Information has been disseminated through webinars and public presentations and by making all components of the Guide available in the public domain at no cost. Employers, benefit consultants, managed care organizations, and pharmacy benefit plans have all shown a high level of interest in the project, with a combined total of almost 47,000 document views and downloads between July 2011 and March 2012. Adoption of the benefit recommendations is already occurring, which we believe will benefit employers, patients, and cancer care providers alike. Physicians may be interested in understanding the project because it will affect their patients' benefits and coverage. State medical societies and other groups may be able to influence employers to adopt the recommendations by providing real-life examples of how offering these benefits can make a different for patients.
Funding is being sought for an actuarial analysis that will quantify the net cost or net savings that can be expected if the benefits are adopted by employers. We are hopeful that funding will be obtained and the analysis published in 2013, as the project's impact is likely to increase with these results. We expect the cost of implementing the recommendations to be modest; in fact, the recommendations may, in some cases, reduce cost of care. This project has been described as "private sector health care reform at its best." By articulating recommendations that are driven by evidence and are accompanied by estimates of likely costs or savings, NCCN and the National Business Group on Health are introducing a model that can influence coverage for the estimated 59% of Americans younger than 65 years who receive employer-sponsored health benefits. 3 The recommendations may be adopted by managed care organizations on behalf of employers who do not self-fund and by CMS. They can also influence what is included in "essential health benefits" for health care exchanges. Finally, the Guide serves as a model that can be followed in developing benefit recommendations for other costly and complex health conditions.
